Uterine Transplantation: Recipient Patient Populations
- PMID: 35045021
- DOI: 10.1097/GRF.0000000000000672
Uterine Transplantation: Recipient Patient Populations
Abstract
Uterine transplantation is an emerging treatment for patients with uterine factor infertility (UFI). In order to determine patient candidacy for transplant, it is imperative to understand how to identify, counsel and treat uterine transplant recipients. In this article, we focus on patient populations with UFI, whether congenital or acquired, including Mayer-Rokitansky-Kuster-Hauser, complete androgen insensitivity syndrome, hysterectomy, and other causes of nonabsolute UFI. Complete preoperative screening of recipients should be required to assess the candidacy of each individual prior to undergoing this extensive treatment option.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Richards EG, Farrell RM, Ricci S, et al. Uterus transplantation: state of the art in 2021. J Assist Reprod Genet. 2021;28:2251–2259.
-
- Dahm-Kähler P, Diaz-Garcia C, Brännström M. Human uterus transplantation in focus. Br Med Bull. 2016;117:69–78.
-
- Putman JM, Zhang L, Gregg AR, et al. Clinical pregnancy rates and experience with in vitro fertilization after uterus transplantation: Dallas Uterus Transplant Study. Am J Obstet Gynecol. 2021;225:155.e1–155.e11.
-
- Brännström M, Johannesson L, Dahm-Kähler P, et al. First clinical uterus transplantation trial: a six-month report. Fertil Steril. 2014;101:1228–1236.
-
- American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care and Amies Oelschalger, A. E. ACOG Comitttee opinion no 827: müllerian agenesis: diagnosis, management, and treatment. Obstet Gynecol. 2018;131:196–197.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical